Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID02920788

Multi-Level Assessment and Rehabilitation of Combat Mild Traumatic Brain Injury

Led by VA Office of Research and Development · Updated on 2026-05-06

65

Participants Needed

2

Research Sites

14 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the effects of a cognitive training program called Goal-Oriented Attentional Self-Regulation (GOALS) on Veterans with chronic mild traumatic brain injury (mTBI) and related conditions. This study aims to see if improving attention, executive function, memory, and emotional regulation through GOALS can enhance daily life and cognitive performance. It also uses advanced MRI to explore changes in brain structure and function linked to these improvements. The study randomly assigns 36 Veterans with chronic mTBI to either the GOALS training or treatment as usual (TAU) for 5 weeks. GOALS is a therapist-led program focusing on mindfulness-based attention regulation and goal management applied to real-life activities. Additionally, 15 healthy Veterans without TBI will participate as a control group, undergoing neuropsychological testing and MRI but no intervention. Participants will be assessed at baseline, after 5 weeks, and at 6 months using brain imaging (3T and 7T MRI, diffusion tensor imaging, resting state fMRI), neuropsychological tests for attention and executive function, real-life task performance, and self-reports on daily functioning and emotional health. The study will monitor cognitive and brain changes over time to understand the lasting effects of GOALS training on Veterans with mTBI.

CONDITIONS

Brief Title

Mild TBI Assessment & Rehabilitation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 18 or older
  • History of mild traumatic brain injury confirmed by medical records and assessment
  • Chronic, stable recovery phase at least 6 months after last concussion
  • Report of moderate or severe cognitive symptoms interfering with daily life
  • Able and willing to participate in training and assessments
  • Stable psychoactive medication use if applicable (at least 30 days)
  • For healthy control group: no history of any traumatic brain injury
  • Willingness to participate in assessments
Not Eligible

You will not qualify if you...

  • History of moderate or severe traumatic brain injury
  • Unstable medical, neurological, or psychiatric conditions including severe cognitive dysfunction
  • Contraindications to MRI
  • Ongoing illicit drug or alcohol abuse (AUDIT score over 8)
  • Psychosis
  • Severe depression, anxiety, or PTSD preventing participation
  • Poor comprehension of English
  • For healthy controls: any history of traumatic brain injury
  • Other unstable neuropsychiatric disorders excluding stable depression or PTSD

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 5 weeks

Participants with mild traumatic brain injury undergo 5 weeks of cognitive training (GOALS) or receive standard clinical care, involving application of mindfulness-based attention regulation and goal management strategies or brain health education.

Weekly visits during the 5-week training period

Monitoring

Duration - 6 months post-treatment

Participants undergo neuropsychological assessments and MRI scans at baseline, week 5, and 6 months to evaluate cognitive function and brain changes following training or standard care.

3 visits (baseline, week 5, 6 months follow-up)

Trial Site Locations

Total: 2 locations

1

San Francisco VA Medical Center, San Francisco, CA

San Francisco, California, United States, 94121-1563

Completed

2

University of California, San Francisco

San Francisco, California, United States, 94158

Actively Recruiting

Loading map...

Research Team

P

Pratik Mukherjee, MD PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

Automated Robotic TCD in Traumatic Brain Injury (ART-TBI)

Brain Injuries, Traumatic

Actively Recruiting

3 locations

Brain Injury Education and Outpatient Navigation for Hispani...

Brain Injuries, Traumatic

Actively Recruiting

6 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Training in Goal-Oriented Attention Self-Regulation Improves Executive Functioning in Veterans with Chronic Traumatic Brain Injury.

Tatjana Novakovic-Agopian, Erica Kornblith, Gary Abrams...

https://pubmed.ncbi.nlm.nih.gov/29717652

Resting-State Connectivity Changes After Goal-Oriented Attentional Self-Regulation Training in Veterans With Mild Traumatic Brain Injury: Preliminary Findings from a Randomized Controlled Trial.

Maria Kryza-Lacombe, Rachel Santiago, Anna Hwang...

https://pubmed.ncbi.nlm.nih.gov/37405257

Goal-Oriented Attentional Self-Regulation Training in Chronic Mild Traumatic Brain Injury is Linked to Microstructural Plasticity in Prefrontal White Matter.

Haleh Karbasforoushan, Jamie Wren-Jarvis, Anna Hwang...

https://pubmed.ncbi.nlm.nih.gov/39470361

Goal-Oriented Attention Self-Regulation Training Improves Executive Functioning in Veterans with Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury.

Tatjana Novakovic-Agopian, Lainie Posecion, Erica Kornblith...

https://pubmed.ncbi.nlm.nih.gov/33019861

Goal-Oriented Attentional Self-Regulation Training Improves Executive Function and Complex Attention in Veterans With mTBI-Randomized-Control Study.

Rachel Santiago, Maria Kryza-Lacombe, Jillian Tessier...

https://pubmed.ncbi.nlm.nih.gov/41838854